Dr. Rebecca Kush Appointed to Represent Research Community on U.S. HIT Standards Committee

On behalf of Farzad Mostashari, the National Coordinator for Health IT, Rebecca Daniels Kush has been invited to serve on the HIT Standards Committee, a federal advisory committee that makes recommendations to the National Coordinator on standards, implementation specifications, and certification criteria for the electronic exchange and use of health information for purposes of adoption, consistent with the implementation of the Federal Health IT Strategic Plan, and in accordance with policies developed by the HIT Policy Committee.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Austin, TX (PRWEB) July 18, 2011

On behalf of Farzad Mostashari, the National Coordinator for Health IT, Rebecca Daniels Kush has been invited to serve on the HIT Standards Committee, a federal advisory committee that makes recommendations to the National Coordinator on standards, implementation specifications, and certification criteria for the electronic exchange and use of health information for purposes of adoption, consistent with the implementation of the Federal Health IT Strategic Plan, and in accordance with policies developed by the HIT Policy Committee.

Dr. Kush was selected to fulfill a requirement of the Department of Health and Human Services (HHS) to appoint a member from the research community to the HIT Standards Committee. The term of this appointment is May 2011 to June 2013.

"The implementation of informatics standards across the continuum of care delivery to clinical research to data archiving and analysis is essential for cost effective and precise progress in health diagnostics, prevention and therapeutics,” states Steven Hirschfeld, MD, PhD, Captain U.S. Public Health Officer, Operations Chief and Chief Medical Officer, USPHS Rapid Deployment Force-1 and Associate Director for Clinical Research and Acting Director, National Children’s Study, Eunice Kennedy Shriver National Institute of Child Health and Human Development. “Dr. Rebecca Kush is ideally qualified for advancing these goals and providing high quality and objective perspective based on her international experience, her leadership, track record and vision."

Rebecca Kush is currently president and CEO of the Clinical Data Interchange Standards Consortium (CDISC), an open, global standards developing organization that has concentrated on developing standards to support medical research and related areas of healthcare for the past 14 years. Dr. Kush has over 30 years of experience in the area of clinical research, including positions with the U.S. National Institutes of Health, academia, a global clinical research organization and biopharmaceutical companies in the U.S. and Japan. She earned her doctorate in Physiology and Pharmacology from the University of California San Diego (UCSD) School of Medicine. She has served on the Board of Directors for the U.S. Health Information Technology Standards Panel (HITSP), Drug Information Association (DIA) and currently Health Level Seven (HL7) and was a member of the advisory committee for the WHO International Clinical Trials Registry Platform. Dr. Kush has served on appointed committees for the Institute of Medicine, provided expert input to the President’s Council of Advisors on Science and Technology (PCAST) and has authored numerous publications for books and journals, including New England Journal of Medicine and Science Translational Medicine.

Dr. Kush was also recently invited by Dr. Harold Varmus to present at the NCI Director’s Industry Liaison Group and to serve as a domain expert on the caBIG Oversight Ad hoc Subcommittee of the National Cancer Institute, Board of Scientific Advisors. The purpose of the Ad hoc subcommittee is to evaluate the scientific merit of the caBIG Program’s ongoing and planned initiatives and to advise the NCI Board of Scientific Advisors (BSA) and the NCI Director about steps that should be taken to improve the caBIG program and to enhance its utility for current and future users of the program.

"On behalf of the CDISC Board of Directors, I would like to thank Becky for her continued commitment to standards in medical research,” said Paula Brown Stafford, Chair-elect of the CDISC Board of Directors and President of Clinical Development, Quintiles. “As the CEO of CDISC she represents over 300 member organizations and will be able to work on their behalf through this new appointment."

About CDISC

CDISC is a global, open, multidisciplinary, neutral non-profit organization that has established standards to support the acquisition, exchange, submission and archive of clinical research data and metadata. The CDISC Healthcare Link Initiative collaborates to link research and healthcare through standards-inspired innovation to further the CDISC mission and vision. The CDISC mission is to develop and support global, platform-independent data standards that enable information system interoperability to improve medical research and related areas of healthcare. The CDISC Vision: Informing patient care and safety through higher quality medical research. CDISC standards are global, vendor-neutral, platform-independent and freely available via the CDISC website. Additional information on CDISC can be found on the CDISC website at http://www.cdisc.org.

###


Contact